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ABSTRACT
A nomenclature is described for restriction endonu-
cleases, DNA methyltransferases, homing endonu-
cleases and related genes and gene products. It
provides explicit categories for the many different
Type II enzymes now identi®ed and provides a sys-
tem for naming the putative genes found by
sequence analysis of microbial genomes.
INTRODUCTION
There are three main groups of restriction endonucleases
(REases) called Types I, II and III (1,2). Since 1973, REases
and DNA methyltransferases (MTases) have been named
based on an original suggestion by Smith and Nathans (3).
They proposed that the enzyme names should begin with a
three-letter acronym in which the ®rst letter was the ®rst letter
of the genus from which the enzyme was isolated and the next
two letters were the ®rst two letters of the species name. Extra
letters or numbers could be added to indicate individual strains
or serotypes. Thus, the enzyme HindII was one of four
enzymes isolated from Haemophilus in¯uenzae serotype d.
The ®rst three letters of the name were italicized. Later, a
formal proposition for naming the genes encoding REases and
MTases was adopted (4). When there were only a handful of
enzymes known, these schemes were very useful, but as more
enzymes have been found, often from different genera and
species with names whose three-letter acronyms would be
identical, considerable laxity in naming conventions has
appeared. In addition, we now know that each major type of
enzyme can contain sub-types. This especially applies to the
Type II enzymes, of which more than 3500 have been
characterized (5). In this paper we revisit the naming
conventions and outline an updated scheme that incorporates
current knowledge about the complexities of these enzymes.
We describe a set of naming conventions for REases and their
associated MTases. Since the homing endonucleases (6) have
been named in an analogous fashion, we propose that similar
guidelines be applied to that group of enzymes. Finally, it is
important to realize that the aim of this document is to provide
a nomenclature for these enzymes, not to provide a rigorous
classi®cation.
GENERAL RULES
First, we introduce a number of general changes, standard
abbreviations and de®nitions that are recommended for use.
1. `Restriction enzyme' and `restriction endonuclease'
should be regarded as synonymous and the abbreviation
REase (or in some cases, R) is preferred. However, the
abbreviation ENase, which has been used extensively, may
also be used. Alternative names such as restrictases should be
avoided. The abbreviation R-M should be used for restriction-
modi®cation. Homing endonuclease should be abbreviated
HEase.
2. Methyltransferase is the preferred name, since it correctly
describes the activity. Methylase, while in common use, is not
strictly accurate and should be avoided in print. The abbre-
viation MTase (or in some cases, M) should be the standard.
3. Italics will no longer be used for the ®rst three-letter
acronym of the REase or MTase name. Many journals already
avoid italics and retaining the italic convention is not easily
translated to computers and serves no essential purpose. The
convention of naming different enzymes from the same isolate
of the same organism with increasing Roman numerals will
continue.
4. Restriction enzyme names should not include a space
between the main acronym and the Roman numeral. This
practice, which has been employed to avoid the inelegant look
caused when characters in italic fonts are juxtaposed next to
characters in a regular font, is incorrect. Now that italics will
no longer be used in names there is no reason to continue this
practice. The previous scheme of using a raised dot after the
pre®x will be abandoned and a normal dot (period) should be
used. Furthermore, except for the single period or hyphen (in
homing endonucleases) that is used to separate the pre®x from
the main part of the name, no punctuation marks, such as
parentheses, periods, commas or slashes, should be used in
REase or MTase names. Only alphanumeric characters should
appear. Already the enzymes from Nostoc species C have been
changed from their original Nsp(7524)I to NspI and many
others have also changed. The most recent is Bst4.4I, which
has changed to Bst44I.
5. The designation of the three main types of REases as
Type I, Type II and Type III will continue, with the capital `T'
preferred. However, they will be divided into subtypes as
indicated below. One new type of REase will be added. This is
Type IV, which will include those systems that cleave only
methylated DNA as their substrate and show only weak
speci®city, such as the McrA, McrBC and Mrr systems of
Escherichia coli.
6. The sequence databases contain many genes that are
excellent candidates to encode DNA MTases and REases,
based on sequence similarity. These will be named according
to the same guidelines as are used for biochemically
characterized enzymes, but will carry the suf®x P to indicate
their putative nature. Once they have been characterized
biochemically and shown to be active, the P will be dropped
and their names will be changed to a regular name with the
next Roman numeral that is appropriate.
7. The current convention of naming R-M enzymes with a
pre®x M, R, etc. will be expanded to include the protein
products of related genes such as the controlling proteins (e.g.
C.BamHI) and the nicking enzymes that cleave G/T mis-
matches (e.g. V.HpaII for the vsr-like enzyme associated with
the HpaII system) and N.BstNBI for the regular nicking
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enzymes. In addition, up to two characters will be allowed in
the pre®x. This will enable enzymes, such as Eco57I, with
both REase activity and MTase activity fused in a single
protein to be designated RM.Eco57I. Its accompanying MTase
would remain as M.Eco57I. Note that the current convention
of permitting the REase to be named either with or without the
`R' pre®x will be continued. Thus, R.EcoRI and EcoRI will be
considered synonymous as will RM.Eco57I and Eco57I. For
certain nicking enzymes that have been obtained from the
Type IIT enzymes, where one of the two heterodimeric
subunits has been inactivated the resultant mutant nicking
enzymes should be called Nt.BbvCI or Nb.BbvCI, where the
`t' and the `b' indicate cleavage of the top or bottom strand of
the normal recognition sequence.
8. When two REase or MTase genes are present and
associated with a single R-M system they should be referred to
with the second character of the pre®x being an Arabic 1 or 2.
Thus, the two M gene products of the HphI R-M system would
be M1.HphI and M2.HphI.
9. The standard abbreviations for methylated bases should
be 5-methylcytosine (m5C), N4-methylcytosine (m4C) and
N6-methyladenine (m6A). It is not necessary to use a
superscript for the number.
10. Isoschizomers are REases that recognize the same
sequence. The ®rst example discovered is called a prototype
and all subsequent enzymes that recognize the same sequence
are isoschizomers of the prototype. Neoschizomers are that
subset of isoschizomers that recognize the same sequence, but
cleave at different positions from the prototype. Thus, AatII
(recognition sequence: GACGT¯C) and ZraI (recognition
sequence: GAC¯GTC) are neoschizomers of one another,
while HpaII (recognition sequence: C¯CGG) and MspI
(recognition sequence: C¯CGG) are isoschizomers, but not
neoschizomers. Analogous designations are not appropriate
for MTases, where the differences between enzymes are not so
easily de®ned and usually have not been well characterized.
11. The solitary MTases (i.e. not associated with an REase)
such as the Dam and Dcm MTases of E.coli and the eukaryotic
MTases such as Dnmt1 and Dnmt3a will be named system-
atically in accordance with the general rules established for the
prokaryotic enzymes. Thus, the systematic name for the Dam
MTase of E.coli K12 will be M.EcoKDam and the murine
maintenance MTase will be M.MmuDnmt1. However, it will
be acceptable to refer to them by their more commonly used
trivial names, Dam, Dcm, Dnmt1, etc., but it will simplify
automated searching and cross-referencing of the literature if
the systematic name, including the M pre®x, also appears at
least initially in a publication. Solitary MTases that are phage
or virus borne are also named with the pre®x M and the name
of the phage or virus that carries them. Optionally, the host
name may be included. Thus, the MTase encoded by phage
SPR of Bacillus subtilis is named M.SPRI (7) and the MTase
encoded by the archaeal virus fCh1 of Natrialba magadii is
named M.NmaPhiCh1I (8).
12. The rules for naming genes of Type II R-M systems
should adhere to the proposals of Szybalski et al. (4) with the
obvious extensions to accommodate C, V and N genes. Thus,
the entire name should be italicized, the ®rst letter will be
lower case and the capital letter(s) used as a pre®x for the
protein will become the suf®x for the gene. The gene for
EcoRI thus becomes ecoRIR and that for its MTase is ecoRIM.
In the case of genes with two pre®xes in the protein name the
gene name would incorporate both letters of the pre®x. Thus,
the gene for RM.Eco57I would become eco57IRM. In the case
of Type I enzymes, an acronym for the source organism should
be followed by the traditional gene designations, hsdS, hsdR
and hsdM. Thus, the three genes of the EcoKI restriction
system would be ecoKIhsdM, ecoKIhsdR and ecoKIhsdS.
However, it will be acceptable to omit the ecoKI where
appropriate.
13. It sometimes happens that two genes are required for a
single enzyme activity, effectively encoding two subunits. In
these situations the two genes and their products should carry a
suf®x A and B. For example, BbvCI is a heterodimeric REase.
The two gene products would be called R.BbvCIA (or just
BbvCIA) and R.BbvCIB (or just BbvCIB), and the active
holoenzyme would be BbvCI. Note that the two separate
MTases of this system would be M1.BbvCI and M2.BbvCI.
For enzymes like Eco57I, which have both endonuclease and
MTase activity in the same polypeptide chain, the endo-
nuclease would be referred to as RM.Eco57I, but the second
MTase activity associated with this system would be called
M.Eco57I. For MTases, an example is M.AquI, which has one
gene encoding the N-terminal region up to the middle of the
variable region of this m5C MTase and a second gene
encoding the remaining C-terminal region (9). In this case, the
two parts of this protein should be referred to as M.AquIA and
M.AquIB and the genes as aquIAM and aquIBM.
DETAILS OF TYPES AND SUBTYPES
Types I, II, III and IV
The original subdivision of Types I, II and III will be
maintained and a new Type IV added to accommodate a class
of methyl-dependent restriction enzymes. The previously
proposed candidates for new types, such as Eco57I and GsuI,
will be incorporated as subtypes of existing Type II enzymes.
Type I
The key characteristics of the Type I R-M systems are that
these enzymes are multisubunit proteins that function as a
single protein complex and usually contain two R subunits,
two M subunits and one S subunit (10). The symbol for Type I
systems is hsd, thus the genes are hsdR, hsdM and hsdS, and
their protein products are HsdR, HsdM and HsdS, respect-
ively. The protein products can be abbreviated by omitting
Hsd. The S subunit is the speci®city subunit that determines
which DNA sequence is recognized. The R subunit is essential
for cleavage (restriction) and the M subunit catalyzes the
methylation reaction: in all known cases the methylated base
formed is m6A. When Type I enzymes act on unmethylated
substrates, they function mainly as REases (they may also
methylate unmodi®ed sites with a low probability) and have
an absolute requirement for ATP during cleavage. They cleave
the DNA at variable positions away from their recognition
sequence. The location of the cleavage sites is determined by
either the collision and stalling of two such complexes during
translocation along a DNA chain, or the stalling of a single
enzyme on a single-site circular substrate following DNA
translocation. The biochemical nature of the termini produced
upon cleavage is unknown and the enzymes do not turn over in
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the cleavage reaction. In contrast, when these complexes
encounter a hemimethylated substrate, in which one strand of
the recognition sequence is methylated, as would occur
immediately after DNA replication of a fully methylated
substrate, then the complex functions as a DNA MTase, using
S-adenosylmethionine (AdoMet) as the donor of the methyl
group. A complex of two M subunits and one S subunit is fully
functional as an MTase. Probably the best known Type I
enzyme is EcoKI (11). The REase is referred to as R.EcoKI or
EcoKI, but it is important to remember that it is also an
MTase. The MTase complex of two HsdM and one HsdS is
referred to as M.EcoKI. When referring to phenotypes the
preferred convention is rKI+ mKI+ etc.
Four sub-categories of Type I enzymes (A, B, C and D) are
in common use (12). These are based on genetic complemen-
tation and their use will be continued. If experimental
evidence de®nes new subtypes, then additional letters may
be used as suf®xes to describe them. A number of arti®cially
created hybrid enzymes have been described (13), which often
include those with new speci®cities. These should be named as
deemed appropriate, but without a Roman numeral at the end.
Type II
The Type II REases recognize speci®c DNA sequences and
cleave at constant positions at or close to that sequence to
produce 5¢-phosphates and 3¢-hydroxyls. Usually they require
Mg2+ ions as a cofactor, although some have more exotic
requirements (see below). They may act as monomers, dimers
or even tetramers and usually act independently of their
companion MTase. The MTases usually act as monomers and
transfer a methyl group from the donor S-adenosyl-L-
methionine directly to double-stranded DNA and form m4C,
m5C or m6A. Because of the interest in these Type II REases
for recombinant DNA technology, more than 3500 have been
characterized (5). Given the assay that is used to ®nd them,
which detects any activity yielding a consistent DNA
fragmentation pattern, it is no surprise that they come in a
large variety of `¯avors'. Early on it was recognized that while
then-normal Type II enzymes recognized palindromic
sequences and cleaved symmetrically within them, the Type
IIS enzymes cut outside their normally asymmetric sequences
and differed in other interesting ways (14). We now know of
additional enzymes that cleave on both sides of their
recognition sequence (e.g. BcgI), are activated by AdoMet
(e.g. Eco57I), interact with two copies of their recognition
sequence (e.g. EcoRII) or have unusual subunit structures (e.g.
BbvCI).
These additional kinds of enzymes will be considered
subdivisions of Type II. It should be recognized that for the
purposes of nomenclature some enzymes would fall into more
than one subdivision. Speci®cally, some of the criteria are
based on the sequence cleaved and others on the structure of
the enzymes themselves, so not all subdivisions are mutually
exclusive, e.g. BcgI is both Type IIB and IIH. Type IIS
enzymes, originally designated as enzymes with cleavage sites
shifted away from their recognition sequence (4), will be
retained, but a new Type IIA will be de®ned that includes all
Type II REases that recognize asymmetric sequences. A new
Type IIP will be used to designate the enzymes that recognize
symmetric sequences (palindromes).
The overriding criterion for inclusion as a Type II enzyme
would be that it yields a de®ned fragmentation pattern and
cleaves either within or close to its recognition sequence at a
®xed site or with known and limited variability. In general, the
Type II REases and their associated MTases are separate,
independent enzymes, but in several classes (e.g. IIB, IIG and
IIH) the R and M genes are fused into a single composite gene.
The nomenclature for the subtypes of the Type II enzymes
currently known is shown below. It should be noted that these
designations are not intended to be exclusive, but rather to
permit enzymes with common characteristics to be referred to
as a group. Conservation of structural domains with associated
enzymatic activities is observed between different classes of
Type II enzymes and also between other types of R-M
enzymes.
The Type II subdivisions are summarized in Table 1 and
described in more detail below.
Type IIP
This would be used as a generic description for all enzymes
that recognize symmetric sequences, often termed palin-
dromes, and cleave at ®xed symmetrical locations either
within the sequence or immediately adjacent to it. The
recognition sequences and cleavage sites of these enzymes
should be represented as in the following example: EcoRI:
G¯AATTC. In full double-stranded form this corresponds to:
5¢ G¯A A T T C
3¢ C T T A A­G
Note that enzymes such as SinI (recognition sequence:
GGWCC), BglI (recognition sequence: GCCNNNN¯NGGC)
and HindII (recognition sequence: GTYRAC) belong to Type
IIP because the recognition mechanism still involves a
symmetric homodimer.
Type IIA
This would be used as a generic designation for any Type II
enzymes that recognize asymmetric sequences irrespective of
whether they cleave away from the sequence or within the
sequence. Typically these systems have one REase gene and
two MTase genes, one to modify each strand of the
asymmetric recognition sequence. However, occasionally
two R genes are found as with Bpu10I (15), or both M
genes are fused as with M.FokI (16). When more than one R or
M gene is present the genes and their protein products should
be named with either an Arabic 1 or 2 in the pre®x of the name.
Thus, the two MTases of the SapI system would be named
M1.SapI and M2.SapI if the proteins are being referred to, or
sapIM1 and sapIM2 for the genes. However, the two subunits
of the Bpu10I REase would be designated R.Bpu10IA and
R.Bpu10IB and their genes bpu10IAR and bpu10IBR. The
recognition sequences and cleavage sites of the Type IIS
REases should be represented as in the following example:
HphI: GGTGA(8/7) where the ®rst numeral in the paren-
theses indicates the position of cleavage on the strand written
and the second numeral indicates the cleavage position on the
complementary strand. In full double-stranded form this
corresponds to:
5¢ GGTGANNNNNNNN¯
3¢ CCACTNNNNNNN­
Note that when recognition sequences are assigned, the
convention is to write the single-stranded sequence such that
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cleavage lies downstream of the sequence. If cleavage takes
place within the sequence, then the single-strand designation
is always written so that the sequence of the strand is ®rst
alphabetically.
Type IIB
This would be used for enzymes that cleave on both sides of
the recognition sequence. At present there are many well
de®ned members of this class (AloI, BplI, Bst44I, BaeI, BcgI,
BsaXI, Bsp24I, CjeI, CjePI, HaeIV, Hin4I and PpiI). In this
case the recognition sequence and cleavage sites should be
represented as exempli®ed for BcgI:
BcgIÐrecognition sequence:
(10/12)CGANNNNNNTGC(12/10)
Here the (10/12) preceding the recognition sequence
indicates that cleavage occurs 10 bases in front of the
sequence on the strand written and 12 bases before the
sequence on the complementary strand. The (12/10) following
the recognition sequence indicates cleavage 12 bases after the
recognition sequence on the strand written and 10 bases after
the sequence on the complementary strand. In double-stranded
form this would be written:
¯NNNNNNNNNNCGANNNNNNTGCNNNNNNNNNNNN¯
­NNNNNNNNNNNNGCTNNNNNNACGNNNNNNNNNN­
Type IIC
This would be used as a generic term for all enzymes that have
a hybrid structure containing both cleavage and modi®cation
domains within a single polypeptide. Examples include all of
the Type IIB, IIG and some Type IIH enzymes.
Type IIE
This would be used for enzymes that interact with two copies
of the recognition sequence, one being the actual target of
cleavage, the other being the allosteric effector. The best
studied examples are EcoRII (17) and NaeI (18). FokI, MboII
and Sau3AI were found to exhibit similar properties. Other
enzymes such as Acc36I, AtuBI, BsgI, BpmI, Cfr9I, Eco57I,
HpaII, Ksp632I, NarI, SacII and SauBMKI are likely to be
members of this group because they are reported to be
stimulated by oligonucleotide duplexes containing the speci®c
recognition site.
Type IIF
This would be used for enzymes that interact with, and cleave
coordinately, two copies of their recognition sequence.
Examples include BspMI, Cfr10I, NgoMIV, S®I and SgrAI.
Type IIG
This would be used for enzymes that have both R and M
domains fused to form single polypeptides and that may be
stimulated or inhibited by AdoMet, but otherwise resemble
Type II enzymes. These include Bce83I, BseMII, BseRI, BsgI,
BspLU11III, Eco57I, GsuI, MmeI and Tth111II. The recog-
nition sequences may or may not be asymmetric. Thus, both
Type IIA and Type IIP enzymes may be of Type IIG.
Type IIH
This would be used for enzymes that contain genetic features
resembling Type I enzymes, but biochemically behave as
Type II enzymes. At present three examples have been
characterized: AhdI and PshAI, both of which comprise a
three gene system akin to that of a typical Type I enzyme
(G.G.Wilson, unpublished results), and BcgI, which is a two
gene system. Several hypothetical systems have gene organ-
izations that resemble that of BcgI.
Table 1. Subtypes of Type II REases
Subtypea De®ning feature Examples Recognition sequence
A Asymmetric recognition sequence FokI GGATG (9/13)
AciI CCGC (±3/±1)
B Cleaves both sides of target on both strands BcgI (10/12) CGANNNNNNTGC (12/10)
C Symmetric or asymmetric target. R and M functions in one polypeptide GsuI CTGGAG (16/14)
HaeIV (7/13) GAYNNNNNRTC (14/9)
BcgI (10/12) CGANNNNNNTGC (12/10)
E Two targets; one cleaved, one an effector EcoRII ¯CCWGG
NaeI GCC¯GGC
F Two targets, both cleaved coordinately S®I GGCCNNNN¯NGGCC
SgrAI CR¯CCGGYG
G Symmetric or asymmetric target. Affected by AdoMet BsgI GTGCAG (16/14)
Eco57I CTGAAG (16/14)
H Symmetric or asymmetric target. Similar to Type I gene structure BcgI (10/12) CGANNNNNNTGC (12/10)
AhdI GACNNN¯NNGTC
M Subtype IIP or IIA. Require methylated target DpnI Gm6 A¯TC
P Symmetric target and cleavage sites EcoRI G¯AATTC
PpuMI RG¯GWCCY
BslI CCNNNNN¯NNGG
S Asymmetric target and cleavage sites FokI GGATG (9/13)
MmeI TCCRAC (20/18)
T Symmetric or asymmetric target. R genes are heterodimers Bpu10I CCTNAGC (±5/±2)b
BslI CCNNNNN¯NNGG
aNote that not all subtypes are mutually exclusive. E.g. BslI is of subtype P and T.
bThe abbreviation indicates double strand cleavage as shown below:
5¢ C C¯T N A G C
3¢ G G A N T­C G
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Type IIM
This would be used for DpnI and similar enzymes that
recognize a speci®c methylated sequence in DNA and cleave
at a ®xed site. Note that the methyl-dependent enzymes such
as McrA, McrBC are not considered members of this subclass,
because they do not have well de®ned recognition sequences
and cleavage sites. They are included within the Type IV
enzymes.
Type IIS
This would be used for Type IIA enzymes that cleave at least
one strand of the DNA duplex outside of the recognition
sequence (i.e. cleavage is shifted relative to the recognition
sequence). Note that for some enzymes, such as BsmI
(recognition sequence: GAATGC), cleavage of the strand
written takes place outside of the recognition sequence,
whereas cleavage of the complementary strand takes place
within the recognition sequence. This is still considered a
Type IIS enzyme. However, in most cases both strands are
cleaved away from the recognition sequence, which therefore
remains intact. These were the earliest sub-classes of the Type
II restriction enzymes to be recognized (14).
Type IIT
This would be used for enzymes that are composed of
heterodimeric subunits. This subtype includes enzymes like
BbvCI, Bpu10I and BslI.
Nicking enzymes
Two types of nicking enzymes are known. One type includes
those that behave functionally like REases, but cleave only
one strand of the DNA substrate. These enzymes should be
named with the pre®x N and their recognition sequences
should be written such that the strand displayed is the strand
nicked. Thus, N.BstSEI has the recognition sequence:
GAGTCNNNN¯ which is abbreviated to GAGTC(4).
Similarly, the mutants of AlwI and MlyI that have interrupted
the dimerization function, and which have become nicking
enzymes, are named N.AlwI (19) and N.MlyI (20). For
enzymes such as Bpu10I, where the wild-type REase has two
subunits, each of which nicks a different strand, the mutant
nicking enzymes made by inactivating one or the other subunit
should be named Nt.Bpu10I for the enzyme that nicks the top
strand of the normal recognition sequence and Nb.Bpu10I for
the enzyme that nicks the bottom strand.
In full double-stranded format Nt.Bpu10I would recognize
5¢ C C¯T N A G C
3¢ G G A N T C G
while Nb.Bpu10I would recognize
5¢ C C T N A G C
3¢ G G A N T­C G
Alternatively this may be written
5¢ G C¯T N A G G
3¢ C G A N T C C
A single-stranded representation of their recognition sites
would be Nt.Bpu10I (recognition sequence: CC¯TNAGC)
and Nb.Bpu10I (recognition sequence: GC¯TNAGG or
CCTNA­GC). Note that the use of ­ always denotes cleavage
of the lower strand.
A second type of nicking enzyme is found exclusively in
association with m5C-MTases, where it serves to nick the G/T
mismatches that can result from deamination of m5C within
the recognition sequence of the MTase. The best studied of
these is the Vsr protein that accompanies the Dcm MTase of
E.coli K-12, M.EcoKDcm. Vsr recognizes the speci®c G/T
mismatch that occurs if there is deamination of the methylated
cytosine residue within the context of the CCWGG recogni-
tion sequence of M.EcoKDcm (21). These kinds of mismatch
nicking enzymes are named with the pre®x V and should be
given the acronym of the MTase gene with which they are
associated. Thus, Vsr, the product of the V gene that overlaps
with the gene for M.EcoKDcm, is systematically named
V.EcoKDcm. However, the trivial name Vsr, which was
originally designated for this protein, is an acceptable
synonym. For other V genes and their products the systematic
names are preferred. Thus, V.HpaII is the preferred name for
the mismatch nicking endonuclease that accompanies
M.HpaII.
Control proteins
Some R-M systems are found to have an additional gene that
encodes a protein involved in the control of expression of the
R gene. The best studied examples are the PvuII and BamHI
systems, where the products of the C genes, C.PvuII (22) and
C.BamHI (23), serve as transcriptional activators; this
prevents the expression of the R genes following transfer of
the systems into naive hosts, until such time as C protein has
accumulated and methylation is suf®cient to provide protec-
tion against what would otherwise be the deleterious action of
the REase.
Type III
These systems are composed of two genes (mod and res)
encoding protein subunits that function either in DNA
recognition and modi®cation (Mod) or restriction (Res)
(10,24,25). Both subunits are required for restriction, which
also has an absolute requirement for ATP hydrolysis. For
DNA cleavage, the enzyme must interact with two copies of a
non-palindromic recognition sequence and the sites must be in
an inverse orientation in the substrate DNA molecule.
Cleavage is preceded by ATP-dependent DNA translocation
as with the Type I REases. The enzymes cleave at a speci®c
distance away from one of the two copies of their recognition
sequence. The Mod subunit can function independently of the
Res subunit to methylate DNA: in all known cases the
methylated base formed is m6A and full modi®cation is
actually hemimethylation. This is not deleterious because of
the requirement for two unmodi®ed sites in inverse repeat
orientation for cleavage. DNA replication puts all of the
unmodi®ed sites in the same orientation. The best-known
examples of Type III enzymes are EcoP1I and EcoP15I.
Putative Type III R-M systems are easily recognized because
of their similarity at the sequence level. When naming the
genes for these enzymes the mod gene of EcoP1I would be
systematically named ecoP1Imod, but the abbreviation mod is
acceptable when it does not result in confusion.
Type IV
These systems are composed of one or two genes encod-
ing proteins that cleave only modi®ed DNA, including
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methylated, hydroxymethylated and glucosyl-hydroxymethy-
lated bases. Their recognition sequences have usually not been
well de®ned except for EcoKMcrBC, which recognizes two
dinucleotides of the general form RmC (a purine followed by a
methylated cytosineÐeither m4C or m5C) and which are
separated by anywhere from 40 to 3000 bases. Cleavage takes
place ~30 bp away from one of the sites. The best studied
example at both the genetic and biochemical level is
EcoKMcrBC of E.coli (26,27), but on the basis of sequence
similarity it is likely that there are many such systems in other
bacteria and archaea. As with the genes of the Type I and Type
III systems, the abbreviations McrBC for the enzyme and
mcrBC for the gene are acceptable.
Hypothetical enzymes
Hypothetical REases and DNA MTases can often be found by
similarity searching in DNA sequences or their presence may
be inferred when speci®c sequences in plasmid or bacterial
DNAs are found to be methylated. It is convenient and useful
to be able to refer to such hypothetical enzymes by name. The
following convention for naming these enzymes is proposed.
They should be named as though they were normal R-M
systems, but should carry the suf®x `P' to indicate their
putative nature. Once biochemical or unequivocal genetic
activity, such as phage restriction, is demonstrated the suf®x
`P' and any open reading frame (ORF) designations can be
dropped allowing the main element of the name to be retained.
Furthermore a Roman numeral should be included to indicate
whether it is the ®rst, second, third, etc. enzyme to be found in
that organism. Note that the P extension should remain with
the gene until such time as a gene product has been
demonstrated to be functional.
This `P' convention is illustrated with genes from
H.in¯uenzae serotype d. Two Type II REases, HindII and
HindIII, and their associated MTases had been characterized
biochemically (28±31). One Type I system had been demon-
strated genetically (32) and the MTase, presumably associated
with this system, had been partially characterized biochem-
ically (30,31). In the genome there are two putative Type I
systems, although only one has a complete set of intact genes
(33). The intact system therefore carries the designation HindI.
In addition to these three systems, there was also known to be
a Dam-like MTase, now called M.HindDam. However, also in
the genome are putative m5C-MTase and REase genes (genes
HI1040 and HI1041) that show high similarity to the known
R-M system, HgiDI (34). The MTase encoded by HI1041
leads to a functional protein with speci®city identical to that of
M.HgiDI (R.D.Morgan, J.Patti and R.J.Roberts, unpublished
results). It is therefore named M.HindV. However, the
adjacent gene for the putative endonuclease is inactive and
so it is named HindVP. One other R-M system can also be
seen in the genome, this time encoding a Type III system.
Neither the R nor the M gene have yet been demonstrated to be
active and so these are named HindORF1056P and
M.HindORF1056P. If they are shown to be active they
would be renamed HindVI and M.HindVI. The convention
here is to name the system after the ORF encoding the MTase
gene. This is to ensure that the two genes are given names that
indicate they are part of the same R-M system.
Homing endonucleases
Homing endonucleases have been classi®ed into four families
according to conserved sequence motifs. These are the
LAGLIDADG, GIY-YIG, H-N-H and His-Cys box families
(35). Nomenclature of the homing endonucleases is patterned
after that of REases, with a three-letter genus-species desig-
nation, followed by a Roman numeral (6). Whereas intron
endonucleases are characterized by the pre®x I- (for intron),
the intein endonucleases are characterized by the pre®x PI-
(for protein insert), and where the endonuclease is not intron-
or intein-encoded, the pre®x is F- (for freestanding). The
systematic nomenclature does not preclude maintaining
historic names. Counter to the original conventions proposed
(6), the above nomenclature will extend to putative homing
endonucleases without demonstrated catalytic activity. As
with hypothetical REases, the suf®x P will be used to denote
the putative nature of the assignment, and the P will be
dropped once nuclease activity has been con®rmed. Hybrid
homing endonucleases will be preceded by the pre®x H-,
followed by the authors' designation, e.g., an I-DmoI/I-CreI
chimera could be H-DreI, or an I-TevI/I-BmoI hybrid could be
H-TevBmo. Those homing endonucleases that have been
characterized biochemically will continue to be listed within
REBASE (5).
Adherence to these conventions and updates
The authors of this proposal have all agreed to follow these
recommendations and it is hoped that other authors and
journals will also adhere to these conventions. If further
changes become appropriate, then REBASE (5) should be
consulted for the latest modi®cations and practices.
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